Carl Adams

Array ( [id] => 11009747 [patent_doc_number] => 20160206701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-21 [patent_title] => 'Formulation comprising a stabilized complex of corticotropin releasing hormone and alpha-2 macroglobulin' [patent_app_type] => utility [patent_app_number] => 14/792608 [patent_app_country] => US [patent_app_date] => 2015-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8208 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11567451 [patent_doc_number] => 20170106096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'HOMOGENOUS ANTIBODY DRUG CONJUGATES VIA ENZYMATIC METHODS' [patent_app_type] => utility [patent_app_number] => 15/317907 [patent_app_country] => US [patent_app_date] => 2015-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23116 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11568909 [patent_doc_number] => 20170107553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'CELL CULTURE PROCESS FOR PRODUCING A PROTEIN' [patent_app_type] => utility [patent_app_number] => 15/315778 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7361 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14294441 [patent_doc_number] => 10287337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents [patent_app_type] => utility [patent_app_number] => 14/727589 [patent_app_country] => US [patent_app_date] => 2015-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27606 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11713619 [patent_doc_number] => 20170182117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC\nSMALL MOLECULES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/313833 [patent_app_country] => US [patent_app_date] => 2015-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 124743 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367090 [patent_doc_number] => 20150252095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'APOLIPOPROTEIN AIV AS AN ANTIDIABETIC PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/704418 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6929 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122008 [patent_doc_number] => 20160318982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHOD FOR PREPARING SINGLE-VALENT, MODIFIED AVIDIN-LIKE MOLECULES AND MODIFIED FUNCTIONAL CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/699671 [patent_app_country] => US [patent_app_date] => 2015-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12124 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11434842 [patent_doc_number] => 20170035863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'Compositions Comprising Variegin' [patent_app_type] => utility [patent_app_number] => 15/304451 [patent_app_country] => US [patent_app_date] => 2015-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8790 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10685799 [patent_doc_number] => 20160031945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'MATERIALS AND METHOD FOR SUPPRESSING INFLAMMATORY AND NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 14/680880 [patent_app_country] => US [patent_app_date] => 2015-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 82 [patent_no_of_words] => 27031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14680880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053415 [patent_doc_number] => 20160250377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'LIGHT ACTIVATED COMPOSITE TISSUE ADHESIVES' [patent_app_type] => utility [patent_app_number] => 14/656994 [patent_app_country] => US [patent_app_date] => 2015-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6499 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14656994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11757278 [patent_doc_number] => 20170204146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'Novel Antimicrobial Peptides' [patent_app_type] => utility [patent_app_number] => 15/123155 [patent_app_country] => US [patent_app_date] => 2015-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5911 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15123155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16413295 [patent_doc_number] => 10821157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Glycotargeting therapeutics [patent_app_type] => utility [patent_app_number] => 14/627297 [patent_app_country] => US [patent_app_date] => 2015-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 28783 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11311697 [patent_doc_number] => 20160347807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'TARGETING P53 AND ITS DNA-BINDING DOMAIN' [patent_app_type] => utility [patent_app_number] => 15/117047 [patent_app_country] => US [patent_app_date] => 2015-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 62716 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15117047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11520561 [patent_doc_number] => 09603942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Somatostatin-dopamine chimeric analogs' [patent_app_type] => utility [patent_app_number] => 14/614458 [patent_app_country] => US [patent_app_date] => 2015-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16949 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14614458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10331936 [patent_doc_number] => 20150216940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'NANOPARTICLE GLUCAGON COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/608311 [patent_app_country] => US [patent_app_date] => 2015-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7125 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11382872 [patent_doc_number] => 20170008929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'SOCS MIMETICS FOR THE TREATMENT OF DISEASES' [patent_app_type] => utility [patent_app_number] => 15/113725 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27661 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248369 [patent_doc_number] => 20150133365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'Polypeptide Having Antibacterial Activity and Angiogenesis-Inducing Activity and Wound-Healing Drug Containing Said Polypeptide' [patent_app_type] => utility [patent_app_number] => 14/604567 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10969 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15483189 [patent_doc_number] => 10556927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Conotoxin peptide k-CPTx-btl03, preparation method therefor, and uses thereof [patent_app_type] => utility [patent_app_number] => 15/539729 [patent_app_country] => US [patent_app_date] => 2014-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3595 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122001 [patent_doc_number] => 20160318975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'METHOD FOR PROMOTING EXPRESSION OF CALRETICULIN, AND SYNTHETIC PEPTIDE FOR USE IN METHOD FOR PROMOTING EXPRESSION OF CALRETICULIN' [patent_app_type] => utility [patent_app_number] => 15/108349 [patent_app_country] => US [patent_app_date] => 2014-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12344 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11289035 [patent_doc_number] => 20160338967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/107355 [patent_app_country] => US [patent_app_date] => 2014-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21915 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15107355 [rel_patent_id] =>[rel_patent_doc_number] =>)